BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    

Ventus Medical Release: Publication of Clinical Trial Data for New Snoring Therapy

8/9/2012 9:54:27 AM

SAN JOSE, Calif., Aug. 8, 2012 /PRNewswire/ -- Ventus Medical announces the publication of clinical trial data for its new Theravent Advanced Nightly Snore Therapy in Sleep Diagnosis and Therapy, a medical journal for sleep professionals (




The randomized, controlled trial of 49 patients demonstrated that successful users of Theravent averaged a 76% reduction in snoring as assessed using a decibel meter. Additionally, bed partners in the study reported a statistically significant reduction in snoring duration and volume. The study also found that the level of snoring reduction with Theravent was on average about five times that of nasal strips. Theravent is available to consumers online at (no prescription required).

"The results of this rigorous study demonstrate very significant improvements in snoring. As a sleep physician, I am delighted and relieved that there is finally a practical snoring treatment that truly works. Theravent should be a welcome option for 45 million snorers in the US and their bed partners who suffer from the effects of snoring," said Philip Westbrook, MD, co-author of the study and Chief Medical Officer of Ventus Medical. "Theravent represents an important, clinically proven option for healthcare providers to recommend to their patients who snore."

Theravent is for people whose snoring affects sleep quality for themselves or their bed partner. Theravent is FDA-cleared and indicated to reduce or eliminate snoring. Theravent uses similar MicroValve Technology first introduced in Ventus Medical's prescription-only Provent Sleep Apnea Therapy. MicroValve Technology has now been proven in more than 15 clinical trials and used for nearly two million nights of sleep. This revolutionary technology increases pressure in the upper airway when a user exhales, creating expiratory positive airway pressure (EPAP), which keeps the airway open and reduces snoring.

About Theravent Advanced Nightly Snore Therapy

Theravent is a new, clinically proven, over-the-counter treatment for snoring. Theravent offers a proven solution for patients whose snoring is affecting the quality of their and their partners' sleep. Used nightly, Theravent gives snorers and their partners a quiet night's sleep. Theravent uses patented MicroValve Technology, previously only available with a prescription, to target and treat snoring. During inhalation, the MicroValves open--allowing nearly unobstructed airflow. During exhalation, the MicroValves partially close, which increases expiratory pressure and keeps the airway open, preventing snoring. Theravent received FDA clearance in June of 2012. Theravent is not intended to treat obstructive sleep apnea. For more information, please visit

About Provent® Sleep Apnea Therapy

Provent Sleep Apnea Therapy is a proprietary medical device for the treatment of obstructive sleep apnea (OSA). The device has proven to be clinically effective in a series of published studies. It is an easy to use, non-invasive disposable treatment that works across mild, moderate and severe OSA. Provent Sleep Apnea Therapy utilizes nasal expiratory positive airway pressure (EPAP) to keep a patient's airway open during sleep. It incorporates a novel MicroValve design that is placed over the nostrils and secured with hypoallergenic adhesive. During inhalation, the valve opens allowing nearly unobstructed airflow. During exhalation, the valve closes, limiting airflow through small openings, which increases expiratory pressure and keeps the airway open, preventing disruption in breathing. Provent Sleep Apnea Therapy is FDA cleared, has CE marking and has been accepted onto the Australian Register of Therapeutic Goods (ARTG). For more information, please visit

About Ventus Medical

Ventus Medical is a privately-held medical device company dedicated to providing non-invasive medical solutions for people with sleep disordered breathing. Based on its innovative MicroValve technology and patented designs, Ventus has developed a unique line of clinically-proven medical devices to address the continuum of sleep disorders from severe obstructive sleep apnea (OSA) to mild snoring. Ventus Medical's devices work by creating expiratory positive airway pressure (EPAP). The company markets Provent Sleep Apnea Therapy, a discreet, easy-to-use nasal device, for the treatment of obstructive sleep apnea and Theravent Snore Therapy an over-the-counter device for the treatment of snoring in the US. Provent Sleep Apnea Therapy is also available in Australia, New Zealand, Hong Kong and Canada.

SOURCE Ventus Medical

Read at